CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1− Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B CellsLei Tao, Wenzheng Jiang, Muhammad Asad Farooq et al.|Cancers|2020Cited by 36
Foxp3 confers long-term efficacy of chimeric antigen receptor-T cells via metabolic reprogrammingCongyi Niu, Feifei Luo, Huan Song et al.|Cell Metabolism|2025Cited by 35
Chimeric antigen receptor clustering via cysteines enhances T-cell efficacy against tumorYuedi Wang, Yiwei Chu, Yiyuan Gao et al.|Cancer Immunology Immunotherapy|2022Cited by 18
Classical Monocytes Shuttling for Precise Delivery of Nanotherapeutics to GlioblastomaCongwen Li, Yiwei Chu, Congyi Niu et al.|Advanced Healthcare Materials|2024Cited by 6
Dynamics of glioma-associated microglia and macrophages reveals their divergent roles in the immune response of brainJiawen Qian, Yiwei Chu, Chen Wang et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 4